How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia

Blood
Adele K Fielding

Abstract

The Philadelphia chromosome is present in approximately 20% to 30% of adults with acute lymphoblastic leukemia (ALL). The poor prognosis of this relatively uncommon acute leukemia has led to the rapid adoption of treatment strategies such as unrelated donor hematopoietic stem cell transplant and tyrosine kinase inhibitors into clinical practice, despite a relative paucity of randomized clinical trials. Recently, there has been a surge of interest in the underlying biology of ALL. In combination with an accumulation of more mature clinical study data in Philadelphia-positive ALL, it is increasingly possible to make more rational and informed treatment choices for patients of all ages. In this article, I review available data and indicate how I personally interpret current evidence to make pragmatic treatment choices with my patients, outside of clinical trials. My strongest recommendation is that all physicians who are treating this rare disease actively seek appropriate clinical trials for their patients wherever possible.

References

Sep 20, 2002·Blood·Hervé DombretUNKNOWN Groupe d'Etude et de Traitement de la Leucémie Aiguë Lymphoblastique de l'Adulte (GET-LALA Group)
Nov 1, 2002·Current Opinion in Oncology·Ramadevi Nimmanapalli, Kapil Bhalla
Dec 12, 2002·Oncogene·Ramadevi Nimmanapalli, Kapil Bhalla
Nov 27, 2004·The New England Journal of Medicine·Mary J LaughlinMary M Horowitz
Aug 16, 2005·British Journal of Haematology·Louise K Jones, Vaskar Saha
Dec 14, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masamitsu YanadaUNKNOWN Japan Adult Leukemia Study Group
Jan 13, 2006·The New England Journal of Medicine·Ching-Hon Pui, William E Evans
Oct 13, 2006·Blood·Adele K FieldingUNKNOWN Eastern Cooperative Oncology Group
Oct 31, 2007·Bone Marrow Transplantation·A K Fielding, A H Goldstone
Apr 15, 2008·Nature·Charles G MullighanJames R Downing
Jan 9, 2009·The New England Journal of Medicine·Charles G MullighanUNKNOWN Children's Oncology Group
Sep 23, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giovanni MartinelliRobin Foà

❮ Previous
Next ❯

Citations

Jun 7, 2012·Current Oncology Reports·Theresa Liu-DumlaoFarhad Ravandi
Jul 25, 2012·Nature Reviews. Cancer·Thomas O'HareMichael W Deininger
May 25, 2011·The Journal of Experimental Medicine·Lynn M Heltemes-HarrisMichael A Farrar
Sep 6, 2011·Current Opinion in Oncology·Josep-Maria Ribera
May 13, 2014·Mayo Clinic Proceedings·Javier MunozRazelle Kurzrock
Dec 3, 2014·Hematology/oncology Clinics of North America·David I MarksRohini Radia
Dec 22, 2012·Leukemia & Lymphoma·Hossein SadrzadehAmir T Fathi
Jun 15, 2011·Expert Review of Hematology·Edward Allan R Sison, Patrick Brown
Nov 19, 2011·Hematology/oncology Clinics of North America·Adele K Fielding
Nov 19, 2011·Hematology/oncology Clinics of North America·Chezi Ganzel, Jacob M Rowe
Mar 1, 2011·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Carlos Graux
Mar 5, 2016·Leukemia & Lymphoma·Prashant A DeshpandePoonkuzhali Balasubramanian
Jun 21, 2013·Pediatrics International : Official Journal of the Japan Pediatric Society·Akihiro WatanabeMasaru Imamura
Apr 29, 2016·JCI Insight·Michelle L ChurchmanCharles G Mullighan
Nov 12, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sebastian GiebelMohamad Mohty
Sep 11, 2014·Cellular Oncology (Dordrecht)·Leander Van Neste, Wim Van Criekinge
Jul 2, 2016·Apoptosis : an International Journal on Programmed Cell Death·Cristian Ruiz-MorenoCarlos Velez-Pardo
Nov 8, 2016·Journal of Pediatric Hematology/oncology·Anirban DasShano Naseem
Jul 7, 2017·Leukemia & Lymphoma·Silvia SalmoiraghiOrietta Spinelli
Jul 12, 2011·Current Oncology Reports·Joseph M Brandwein
Nov 8, 2017·Oncotarget·Sina Reckel, Oliver Hantschel
Jun 13, 2019·Oncology Letters·Uriel Francisco Santana-BejaranoAlfredo Corona-Rivera
Mar 12, 2013·Current Hematologic Malignancy Reports·A K Fielding, G A Zakout
Jun 13, 2015·Cancer Control : Journal of the Moffitt Cancer Center·Mohammad Hussaini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.